These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 12945207)

  • 21. Rabies DNA vaccine encoding lysosome-targeted glycoprotein supplemented with Emulsigen-D confers complete protection in preexposure and postexposure studies in BALB/c mice.
    Kaur M; Saxena A; Rai A; Bhatnagar R
    FASEB J; 2010 Jan; 24(1):173-83. PubMed ID: 19741168
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Therapeutic activity of the combined use of an interferon inducer and vaccine in experimental rabies].
    Gribencha SV; Nosik NN; Ershov FI; Barinskiĭ IF
    Vopr Virusol; 1983; 28(5):590-4. PubMed ID: 6659475
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of administered interferon on rabies in rabbits.
    Postic B; Fenje P
    Appl Microbiol; 1971 Sep; 22(3):428-31. PubMed ID: 4330317
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vivo detection of specific cell-mediated immunity in street rabies virus infection in mice.
    Tsiang H; Lagrange PH
    J Gen Virol; 1980 Mar; 47(1):183-91. PubMed ID: 6988546
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Immunogenic properties of the liposomal form of the rabies vaccine].
    Gribencha SV; Kobrinskiĭ GD; Safarov SA; Vuchetich LV; Barinskiĭ IF
    Vopr Virusol; 1988; 33(4):431-3. PubMed ID: 3195143
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of rabies virus multiplication by siRNA delivered through adenoviral vector in vitro in BHK-21 cells and in vivo in mice.
    Sonwane AA; Dahiya SS; Saini M; Chaturvedi VK; Singh RP; Gupta PK
    Res Vet Sci; 2012 Aug; 93(1):498-503. PubMed ID: 21767857
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selection of an aptamer against rabies virus: a new class of molecules with antiviral activity.
    Liang HR; Hu GQ; Xue XH; Li L; Zheng XX; Gao YW; Yang ST; Xia XZ
    Virus Res; 2014 May; 184():7-13. PubMed ID: 24486485
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [An application of desoxyribonuclease in experimental rabies].
    Dediuk EA
    Mikrobiol Zh; 1967; 29(4):308-11. PubMed ID: 5619953
    [No Abstract]   [Full Text] [Related]  

  • 29. The efficacy of a new single post-exposure treatment of rabies in mice without vaccination.
    Bijlenga G
    Vet Q; 2001 Nov; 23(4):187-90. PubMed ID: 11765237
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of antiviral activity of phenolic compounds and derivatives against rabies virus.
    Chávez JH; Leal PC; Yunes RA; Nunes RJ; Barardi CR; Pinto AR; Simões CM; Zanetti CR
    Vet Microbiol; 2006 Aug; 116(1-3):53-9. PubMed ID: 16697126
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of administered human interferon on experimental rabies in monkeys.
    Hilfenhaus J; Karges HE; Weinmann E; Barth R
    Infect Immun; 1975 May; 11(5):1156-8. PubMed ID: 1168171
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antiviral Ranpirnase TMR-001 Inhibits Rabies Virus Release and Cell-to-Cell Infection In Vitro.
    Smith TG; Jackson FR; Morgan CN; Carson WC; Martin BE; Gallardo-Romero N; Ellison JA; Greenberg L; Hodge T; Squiquera L; Sulley J; Olson VA; Hutson CL
    Viruses; 2020 Feb; 12(2):. PubMed ID: 32033253
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In Vivo Bioluminescent Imaging of Rabies Virus Infection and Evaluation of Antiviral Drug.
    Yamada K; Nishizono A
    Methods Mol Biol; 2022; 2524():347-352. PubMed ID: 35821486
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Post-exposure local treatment of mice infected with rabies with two axonal flow inhibitors, colchicine and vinblastine.
    Bulenga G; Heaney T
    J Gen Virol; 1978 May; 39(2):381-5. PubMed ID: 77308
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Production, purification and analysis of an experimental DNA vaccine against rabies.
    Diogo MM; Ribeiro SC; Queiroz JA; Monteiro GA; Tordo N; Perrin P; Prazeres DM
    J Gene Med; 2001; 3(6):577-84. PubMed ID: 11778904
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human rabies therapy: lessons learned from experimental studies in mouse models.
    Jackson AC; Scott CA; Owen J; Weli SC; Rossiter JP
    Dev Biol (Basel); 2008; 131():377-85. PubMed ID: 18634499
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of 9-(S)-(2,3-dihydroxypropyl)adenine on experimental rabies infection in laboratory mice.
    Sodja I; Holý A
    Acta Virol; 1980 Sep; 24(5):317-24. PubMed ID: 6108059
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Experimental and clinical study of immunomodulators Immunomax and Gepon in complex treatment of acute purulent surgical infection].
    Chadaev AP; Nurpisov AM
    Antibiot Khimioter; 2004; 49(7):9-16. PubMed ID: 15690909
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Corynebacterium granulosum-derived P40 immunomodulator exerts a synergistic effect on the activity of antiviral drugs in the treatment of experimental viral infections.
    Fattal-German M; Bizzini B
    Biomed Pharmacother; 1988; 42(3):217-20. PubMed ID: 3179407
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Prophylactic and therapeutic activity of an interferon inducer in mice infected intracerebrally with rabies street virus].
    Gribencha SV; Nosik NN; Ershov FI; Barinskiĭ IF
    Vopr Virusol; 1983; 28(1):71-4. PubMed ID: 6189300
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.